| 注册
首页|期刊导航|中国临床药理学杂志|甲硝唑片在中国健康受试者中的生物等效性研究

甲硝唑片在中国健康受试者中的生物等效性研究

彭秀晴 郭彩会 刘亚丽 赵娜 宋浩静 白万军 董占军

中国临床药理学杂志2024,Vol.40Issue(13):1943-1947,5.
中国临床药理学杂志2024,Vol.40Issue(13):1943-1947,5.DOI:10.13699/j.cnki.1001-6821.2024.13.020

甲硝唑片在中国健康受试者中的生物等效性研究

Bioequivalence test of metronidazole tablets in healthy human in China

彭秀晴 1郭彩会 1刘亚丽 2赵娜 1宋浩静 1白万军 1董占军1

作者信息

  • 1. 河北省人民医院药学部Ⅰ期临床研究室河北省临床药学重点实验室,河北石家庄 050050
  • 2. 石家庄四药有限公司,河北石家庄 052100
  • 折叠

摘要

Abstract

Objective To evaluate the bioequivalence of metronidazole tablet and reference formulation in Chinese healthy subjects.Methods A single-dose,two-cycle,randomized,open,self-crossover trial was designed with 48 healthy subjects randomly assigned to fasting or postprandial group.For each group,a single oral dose of metronidazole tablet(200 mg)or a reference preparation(200 mg)per cycle were enrolled.The concentration of metronidazole in plasma was measured by high performance liquid chromatography tandem mass spectrometry(HPLC-MS/MS).The non-compartmental model was applied to calculate the pharmacokinetic parameters for bioequivalence analysis via SAS 9.3 software.Results The main pharmacokinetic parameters of test and reference metronidazole tablets in the fasting group were as follows,the Cmax were(4 855.00±1 383.97)and(4 799.13±1 195.32)ng·h·mL-1;the AUC0-t were(54 834.68±12 697.88)and(55 931.35±11 935.28)ng·h·mL-1;the AUC0-∞ were(56 778.09±13 937.76)and(57 922.83±13 260.54)ng·h·mL-1;the Tmax were respectively 1.17 and 1.00 h;t1/2 were(8.99±1.76)and(9.11±1.73)h,respectively.The ratio of the geometric mean and its 90%confidence intervals(CI)of Cmax,AUC0-t and AUC0-∞ were all within the equivalent interval of 80.00%-125.00%.As for postprandial conditions,the main pharmacokinetic parameters of test and reference metronidazole tablets were as follows,the Cmax were(4 057.08±655.08)and(4 044.17±773.98)ng·h·mL-1;the AUC0-t were(55 956.42±12 228.12)and(55 121.04±11 784.55)ng·h·mL-1;the AUC0-∞ were(58 212.83±13 820.00)and(57 350.38±13 229.46)ng·h·mL-1;the Tmax were 2.50 and 2.25 h;the t1/2 were(9.37±1.68)and(9.37±1.79)h,respectively.The ratio of the geometric mean and 90%CI of Cmax,AUC0-t and AUC0-∞ were all within the equivalent interval of 80.00%-125.00%.Conclusion The two preparations were bioequivalent to Chinese healthy adult volunteers under both fasting and fed conditions.

关键词

甲硝唑/液相色谱-串联质谱法/生物等效性/药代动力学

Key words

metronidazole/liquid chromatography-tandem mass spectrometry/bioequivalence/pharmacokinetic

分类

医药卫生

引用本文复制引用

彭秀晴,郭彩会,刘亚丽,赵娜,宋浩静,白万军,董占军..甲硝唑片在中国健康受试者中的生物等效性研究[J].中国临床药理学杂志,2024,40(13):1943-1947,5.

中国临床药理学杂志

OA北大核心CSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文